Investor FAQs

Investor FAQs

Show All
Where is Prelude Therapeutics Headquartered?
200 Powder Mill Road, Wilmington, Delaware 19803, USA.
Where is Prelude Therapeutics Incorporated?
Prelude Therapeutics is incorporated in Delaware.
When was Prelude Therapeutics Founded?
Prelude Therapeutics was founded in 2016.
Which stock exchange are Prelude Therapeutics shares traded on and what is the company’s ticker?
Prelude Therapeutics’ shares are traded on the Nasdaq Global Select Market under the symbol “PRLD”. 
When did the company go public?
Prelude's common shares first started trading on the Nasdaq Global Select Market on 9/25/2020.
When does Prelude Therapeutics’ fiscal year end?
Prelude Therapeutics’ fiscal year ends on December 31.
Who is Prelude Therapeutics’ independent registered public accounting firm?
Ernst & Young LLP.
What is Prelude Therapeutics’ CUSIP number?
74065P 101
How can I purchase Prelude Therapeutics shares?
Shares of Prelude Therapeutics’ stock can be purchased by contacting a securities broker of your choice.
Does Prelude Therapeutics pay dividends and have a dividend reinvestment program?
Prelude Therapeutics does not pay dividends at this time.
Who is Prelude Therapuetics’ transfer agent?
Computershare Trust Company, N.A.
150 Royall Street
Canton, Massachusetts 02021
(800) 962-4284
How can I replace my lost stock certificates?
If you have misplaced your share certificates, please contact Prelude Therapeutics’ transfer agent, Computershare via the information provided above.
How do I report a change of mailing address?
If the shares are held in your name, you must contact Prelude Therapeutics’ transfer agent, Computershare, via the information provided above. If your shares are held in street name, you must contact your broker to update your address.
How can I view documents Prelude Therapeutics has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Quarterly & Annual reports and other investor materials are available in the “Investors” section of Prelude Therapeutics’ corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.
How can I sign up to receive Prelude Therapeutics press releases and other company information?
Please click here to be directed to the email alerts page.
Whom should I contact if I have additional questions?
For media and investor inquires, please send an email to prelude@argotpartners.com.
Investor Tools